← Back to catalogue

β-Hydroxybutyrate 21 Bi-Level Controls

FDA UDI

Class I (US FDA UDI)

by DiaSys Diagnostic Systems GmbH

Identity

Trade Name
β-Hydroxybutyrate 21 Bi-Level Controls FDA UDI
Generic Name
Beta-hydroxybutyrate IVD, control FDA UDI
Device Name
For use as controls in quantative procedures for β-Hydroxybutyrate FDA UDI
Model / Reference
595409943084 FDA UDI
Description
For use as controls in quantative procedures for β-Hydroxybutyrate FDA UDI

Identifiers

Catalog Number
595409943084 FDA UDI
Primary DI / UDI-DI
04051839002921 FDA UDI
FDA Product Code
JJX FDA UDI
GMDN Term
Beta-hydroxybutyrate IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Beta-hydroxybutyrate IVD, control

β-Hydroxybutyrate 21 Bi-Level Controls by DiaSys Diagnostic Systems GmbH — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Beta-hydroxybutyrate IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI b6ace5fa-9e0d-4126-b955-cbb9203ac214 35 fields · synced May 30, 2026